FIN.DE TUBIZE ACT.NOUV.
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.
FIN.DE TUBIZE ACT.NOUV. (FTD) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, FIN.DE TUBIZE ACT.NOUV. (FTD) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
FIN.DE TUBIZE ACT.NOUV. - Net Assets Trend (None–None)
This chart illustrates how FIN.DE TUBIZE ACT.NOUV.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FIN.DE TUBIZE ACT.NOUV. (None–None)
The table below shows the annual net assets of FIN.DE TUBIZE ACT.NOUV. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to FIN.DE TUBIZE ACT.NOUV.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
FIN.DE TUBIZE ACT.NOUV. Competitors by Market Cap
The table below lists competitors of FIN.DE TUBIZE ACT.NOUV. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Campbell Soup Co.
LSE:0HST
|
$4.17 Billion |
|
Saputo Inc
PINK:SAPIF
|
$4.17 Billion |
|
Bright Horizons Family Solutions Inc
NYSE:BFAM
|
$4.17 Billion |
|
Hensoldt AG
PINK:HNSDF
|
$4.17 Billion |
|
Københavns Lufthavne A/S
F:KLH
|
$4.17 Billion |
|
Yara International ASA
PINK:YRAIF
|
$4.16 Billion |
|
Hua Xia Bank Co Ltd
SHG:600015
|
$4.16 Billion |
|
Samsung Securities
KO:016360
|
$4.16 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FIN.DE TUBIZE ACT.NOUV.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares FIN.DE TUBIZE ACT.NOUV.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently FIN.DE TUBIZE ACT.NOUV. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares FIN.DE TUBIZE ACT.NOUV.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FIN.DE TUBIZE ACT.NOUV. (FTD) | €- | N/A | N/A | $4.17 Billion |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |